Results 231 to 240 of about 158,759 (293)

Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Background Older adults with type 2 diabetes (T2DM) are less likely to receive sodium–glucose cotransporter‐2 (SGLT2) inhibitors, despite their proven cardio‐renal benefits and safety. Whether this age‐related gap is driven by frailty, sex, or other factors remains unclear.
Changyuan Yang   +6 more
wiley   +1 more source

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER)

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the real‐world effectiveness of semaglutide versus tirzepatide in reducing major adverse cardiovascular events (MACE) among patients with overweight/obesity and established atherosclerotic cardiovascular disease (ASCVD) without diabetes in an insured US population.
Lauren Wilson   +6 more
wiley   +1 more source

Machine learning prediction of moderate‐to‐severe acute kidney injury after ICU admission and cardiac surgery with urine trace elements

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Acute kidney injury (AKI) is a frequent complication after ICU admission and cardiac surgery. In this study, 149 ICU patients and 144 post–cardiac surgery patients were evaluated using urinary trace elements with eight machine learning (ML) algorithms. LightGBM, Random Forest and XGBoost showed the highest predictive performance (AUCs .71–.85).
Yang Chen   +4 more
wiley   +1 more source

Effectiveness of direct oral anticoagulants for all‐cause mortality and cardiovascular events in overweight and obese patients with atrial fibrillation: Insight from the nationwide START registry

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
This study shows that overweight and obese patients with atrial fibrillation experience improved outcomes when treated with DOACs compared with VKAs. Specifically, DOAC use was associated with lower risks of all‐cause mortality and cardiovascular events.
Danilo Menichelli   +58 more
wiley   +1 more source

Breast implant rupture during coronary artery bypass grafting in a transgender woman. [PDF]

open access: yesKardiochir Torakochirurgia Pol
Beyazal OF   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy